会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明申请
    • NG TUBE WITH GASTRIC VOLUME DETECTION
    • NG管与胃体积检测
    • US20100274225A1
    • 2010-10-28
    • US12669783
    • 2008-07-18
    • Vasu Nishtala
    • Vasu Nishtala
    • A61M31/00
    • A61B5/036A61B5/204A61B5/42A61B5/4211A61B5/4233A61B5/4238A61B5/6852
    • An enteral tube includes a built-in Gastric Residual Volume (GRV) detection sensor at the distal end and a GRV indicating device at the proximal end for indicating the current GRV without requiring the aspiration of any stomach contents. The enteral tube with integrated GRV detection sensor is flexible and long enough to be looped around within the stomach. Weights may be employed to keep the sensor located generally at the lowest portion of the gastric cavity. The GRV detection sensor may include a sealed air column terminating with a flexible membrane. When the enteral tube and sealed air column are inserted into the stomach and submerged in gastric contents, pressure is exerted against the flexible membrane, and therefore against the sealed air column. A pressure sensor detects the pressure within the sealed air column and provides a signal or level representative of the amount of gastric contents in the stomach.
    • 肠管包括在远端的内置的胃残留体积(GRV)检测传感器和近端的GRV指示装置,用于指示当前的GRV,而不需要吸入任何胃内容物。 具有集成GRV检测传感器的肠管灵活,足够长,能够在胃内环绕。 可以采用重量来保持传感器大致位于胃腔的最低部分。 GRV检测传感器可以包括终止于柔性膜的密封空气柱。 当肠管和密封空气柱插入胃中并浸没在胃内容物中时,对柔性膜施加压力,因此对密封空气柱施加压力。 压力传感器检测密封空气柱内的压力,并提供代表胃中胃内容物量的信号或水平。
    • 32. 发明申请
    • Stent improvements
    • 支架改良
    • US20050240278A1
    • 2005-10-27
    • US10833210
    • 2004-04-26
    • Peter AliskiVasu NishtalaBenedict ShiaAnthony Tremaglio
    • Peter AliskiVasu NishtalaBenedict ShiaAnthony Tremaglio
    • A61M1/00A61F2/04A61M29/00
    • A61F2/04A61M27/008
    • In accordance with the invention, there are provided medical devices for providing a fluid passage between two areas in the body. An embodiment of the present invention relates to a stent comprising a tubular member at least a portion of which comprises a reinforcement structure. The tubular member includes a wall and an axial lumen therein having a lumen surface. The reinforcement structure extends at least a portion of a length of the body portion adjacent the distal end portion. One advantage of this embodiment of the invention is, for example, that the reinforcement structure increases patient comfort by providing enhanced flexibility. A second advantage of this embodiment of the invention is, for example, that the reinforcement structure improves axial stiffness and radial stiffness allowing for a thinner tubular member wall thickness and larger lumen diameter.
    • 根据本发明,提供了用于在体内的两个区域之间提供流体通道的医疗装置。 本发明的实施例涉及一种支架,其包括管状构件,其至少一部分包括加强结构。 管状构件包括具有内表面的壁和其中的轴向腔。 加强结构延伸主体部分的与远端部分相邻的长度的至少一部分。 本发明的这个实施例的一个优点是,例如,加强结构通过提供增强的灵活性来增加患者的舒适度。 本发明的该实施例的第二个优点是,例如,加强结构提高了轴向刚度和径向刚度,从而允许更薄的管状部件壁厚度和较大的管腔直径。
    • 33. 发明申请
    • Stent kidney curl improvements
    • 支架肾功能改善
    • US20050240141A1
    • 2005-10-27
    • US10832889
    • 2004-04-26
    • Peter AliskiVasu NishtalaBenedict ShiaAnthony Tremaglio
    • Peter AliskiVasu NishtalaBenedict ShiaAnthony Tremaglio
    • A61F2/84A61F2/04A61M5/00A61M25/00A61M29/02
    • A61M27/008
    • The present invention provides embodiments of medical devices that provide for fluid drainage while maintaining patient comfort. An embodiment of the present invention provides a stent comprising a body portion and a kidney curl portion, the body portion comprising a tubular member having an axial lumen therein adapted to provide fluid communication from one body location to another. The kidney curl portion comprises an elongated filament that has a three-dimensional configuration that substantially conforms to the three-dimensional randomly convoluting calyx space of a kidney. In another embodiment, the kidney curl portion comprises a plurality of petals adapted to flare outwardly from the body portion distal end when in a free state in the space of a kidney so as to prevent the migration of the kidney curl portion into the ureter.
    • 本发明提供了提供流体排出同时保持患者舒适度的医疗装置的实施例。 本发明的实施例提供一种支架,其包括主体部分和肾部卷曲部分,所述主体部分包括管状部件,所述管状部件具有其中的轴向腔,其适于提供从一个身体位置到另一个身体位置的流体连通。 肾卷曲部分包括具有基本上符合肾脏的三维随机卷积的花萼空间的三维构造的细长细丝。 在另一个实施例中,肾卷曲部分包括多个花瓣,其适于在肾脏空间处于自由状态时从身体部分远端向外张开,以防止肾卷曲部分向输尿管移动。
    • 35. 发明授权
    • Injection systems
    • 注射系统
    • US08500681B2
    • 2013-08-06
    • US13053024
    • 2011-03-21
    • Robert R. GonnelliDavid LipsonVasu NishtalaCiro Dimeglio
    • Robert R. GonnelliDavid LipsonVasu NishtalaCiro Dimeglio
    • A61M37/00A61M5/30
    • A61M5/30A61M5/2046A61M5/2066A61M5/2459A61M5/46A61M5/484
    • The invention in general relates to various injection systems and devices that can be used, for example, in needleless injection systems for human, and for domestic and farm animals. In certain embodiments, the invention provides an injection system comprising: an injector defining a first cavity in fluid communication with an orifice configured for needleless injection; a housing defining a second cavity, the housing different than the injector; a first movable member between the first cavity and the second cavity, wherein the first movable member is configured to transfer a fluid from the second cavity to the first cavity; and wherein the first movable member is configured to be substantially stationary until the first movable member is moved by a propellant.
    • 本发明一般涉及可用于例如人类的无针注射系统以及家畜和农场动物的各种注射系统和装置。 在某些实施例中,本发明提供了一种注射系统,包括:喷射器,其限定与构造成用于无针注射的孔口流体连通的第一空腔; 限定第二腔的壳体,所述壳体不同于所述注射器; 在所述第一腔和所述第二腔之间的第一可移动构件,其中所述第一可移动构件构造成将流体从所述第二空腔传送到所述第一空腔; 并且其中所述第一可移动构件构造成基本上静止,直到所述第一可移动构件被推进剂移动。
    • 37. 发明授权
    • Injection systems
    • 注射系统
    • US07931614B2
    • 2011-04-26
    • US10001002
    • 2001-11-30
    • Robert R. GonnelliDavid LipsonVasu NishtalaCiro Dimeglio
    • Robert R. GonnelliDavid LipsonVasu NishtalaCiro Dimeglio
    • A61M5/30A61M37/00
    • A61M5/30A61M5/2046A61M5/2066A61M5/2459A61M5/46A61M5/484
    • The invention in general relates to various injection systems and devices that can be used, for example, in needleless injection systems for human, and for domestic and farm animals. In certain embodiments, the invention provides an injection system comprising: an injector defining a first cavity in fluid communication with an orifice configured for needleless injection; a housing defining a second cavity, the housing different than the injector; a first movable member between the first cavity and the second cavity, wherein the first movable member is configured to transfer a fluid from the second cavity to the first cavity; and wherein the first movable member is configured to be substantially stationary until the first movable member is moved by a propellant.
    • 本发明一般涉及可用于例如人类的无针注射系统以及家畜和农场动物的各种注射系统和装置。 在某些实施例中,本发明提供了一种注射系统,包括:喷射器,其限定与构造成用于无针注射的孔口流体连通的第一空腔; 限定第二腔的壳体,所述壳体不同于所述注射器; 在所述第一腔和所述第二腔之间的第一可移动构件,其中所述第一可移动构件构造成将流体从所述第二空腔传送到所述第一空腔; 并且其中所述第一可移动构件构造成基本上静止,直到所述第一可移动构件被推进剂移动。
    • 40. 发明申请
    • RENAL MONITOR
    • US20100121220A1
    • 2010-05-13
    • US12527977
    • 2008-02-18
    • Vasu Nishtala
    • Vasu Nishtala
    • A61B5/20
    • A61B5/201A61B5/0084A61B5/14507A61B5/14546A61B5/1473A61B5/208A61B5/412A61B2562/0238G01N33/70G01N2800/347
    • A continuous Glomerular Filtration Rate (GFR) estimation system may include a Foley catheter, a continuous urine creatinine sensor, and a urine output monitor. The continuous GFR estimation system computes creatinine clearance as CrCl=(Ucr×Uvol)/(Pcr×Imim), where Ucr is urine creatinine in mg/dL, Uvol is urine volume in mL, Pcr is plasma (serum) creatinine in mL, and Imin is time in minutes. A Foley catheter may be used to withdraw urine from the bladder. The urine may be delivered to a urine output monitor that provides the Uvol value over a time Imin. Attached to the catheter is the flow-through continuous urine creatinine sensor for providing the Ucr value. The remaining parameter is Pcr. Because serum creatinine levels do not change rapidly over time, a blood sample may be withdrawn prior to the start of the continuous GFR to obtain the PCr value.
    • 连续的肾小球滤过率(GFR)估计系统可以包括Foley导管,连续尿肌酐传感器和尿液输出监测器。 连续GFR估计系统计算肌酐清除率为CrCl =(Ucr×Uvol)/(Pcr×Imim),其中Ucr为尿肌酐,单位为mg / dL,Uvol为尿量,mL,Pcr为血浆(血清)肌酐,单位为mL, 而Imin是几分钟的时间。 Foley导管可用于从膀胱抽出尿液。 尿液可以输送到尿液输出监测器,在一段时间内提供Uvol值。 连接到导管是用于提供Ucr值的流通连续尿肌酐传感器。 剩余的参数是Pcr。 由于血清肌酐水平随着时间的推移不会迅速变化,因此可以在连续GFR开始之前撤回血液样本以获得PCr值。